BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21573214)

  • 1. Oncogenic LMO3 collaborates with HEN2 to enhance neuroblastoma cell growth through transactivation of Mash1.
    Isogai E; Ohira M; Ozaki T; Oba S; Nakamura Y; Nakagawara A
    PLoS One; 2011 May; 6(5):e19297. PubMed ID: 21573214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.
    Aoyama M; Ozaki T; Inuzuka H; Tomotsune D; Hirato J; Okamoto Y; Tokita H; Ohira M; Nakagawara A
    Cancer Res; 2005 Jun; 65(11):4587-97. PubMed ID: 15930276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Lmo3 cooperates with Hen2 to induce hydrocephalus in mice.
    Isogai E; Okumura K; Saito M; Yoshizawa Y; Itoh K; Tando S; Ohira M; Haraguchi S; Nakagawara A; Fushiki S; Nagase H; Wakabayashi Y
    Exp Anim; 2015; 64(4):407-14. PubMed ID: 26156403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jmjd3 activates Mash1 gene in RA-induced neuronal differentiation of P19 cells.
    Dai JP; Lu JY; Zhang Y; Shen YF
    J Cell Biochem; 2010 Aug; 110(6):1457-63. PubMed ID: 20506217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMO3 interacts with p53 and inhibits its transcriptional activity.
    Larsen S; Yokochi T; Isogai E; Nakamura Y; Ozaki T; Nakagawara A
    Biochem Biophys Res Commun; 2010 Feb; 392(3):252-7. PubMed ID: 19995558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma.
    Watt F; Watanabe R; Yang W; Agren N; Arvidsson Y; Funa K
    Cancer Gene Ther; 2007 Mar; 14(3):287-96. PubMed ID: 17124508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The highly related LIM factors, LMO1, LMO3 and LMO4, play different roles in the regulation of the pituitary glycoprotein hormone alpha-subunit (alpha GSU) gene.
    Susa T; Ishikawa A; Cai LY; Kato T; Matsumoto K; Kitahara K; Kurokawa R; Ono T; Kato Y
    Biosci Rep; 2009 Oct; 30(1):51-8. PubMed ID: 19228115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bHLH transcription factors and mammalian neuronal differentiation.
    Kageyama R; Ishibashi M; Takebayashi K; Tomita K
    Int J Biochem Cell Biol; 1997 Dec; 29(12):1389-99. PubMed ID: 9570134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma-specific cytotoxicity mediated by the Mash1-promoter and E. coli purine nucleoside phosphorylase.
    Arvidsson Y; Sumantran V; Watt F; Uramoto H; Funa K
    Pediatr Blood Cancer; 2005 Jan; 44(1):77-84. PubMed ID: 15390277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
    Zhang H; Pu J; Qi T; Qi M; Yang C; Li S; Huang K; Zheng L; Tong Q
    Oncogene; 2014 Jan; 33(3):387-97. PubMed ID: 23222716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HEN1 and HEN2: a subgroup of basic helix-loop-helix genes that are coexpressed in a human neuroblastoma.
    Brown L; Espinosa R; Le Beau MM; Siciliano MJ; Baer R
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8492-6. PubMed ID: 1528853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.
    Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP
    Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.
    Lu JP; Zhang J; Kim K; Case TC; Matusik RJ; Chen YH; Wolfe M; Nopparat J; Lu Q
    Mol Cancer; 2010 Nov; 9():304. PubMed ID: 21106062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the proneural gene encoding Mash1 suppresses MYCN mitotic activity.
    Alvarez-Rodríguez R; Pons S
    J Cell Sci; 2009 Mar; 122(Pt 5):595-9. PubMed ID: 19208763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
    Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
    J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.
    Murphy DM; Buckley PG; Bryan K; Das S; Alcock L; Foley NH; Prenter S; Bray I; Watters KM; Higgins D; Stallings RL
    PLoS One; 2009 Dec; 4(12):e8154. PubMed ID: 19997598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
    Smith AG; Popov N; Imreh M; Axelson H; Henriksson M
    J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
    Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG
    FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway.
    Chen Y; Tsai YH; Tseng SH
    Surgery; 2013 Jan; 153(1):4-16. PubMed ID: 22703967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive auto-regulation of MYCN in human neuroblastoma.
    Suenaga Y; Kaneko Y; Matsumoto D; Hossain MS; Ozaki T; Nakagawara A
    Biochem Biophys Res Commun; 2009 Dec; 390(1):21-6. PubMed ID: 19766596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.